Saniona AB (LTS:0RQJ) Buyback Yield %: -6.41 (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RQJ Saniona AB LTS:0RQJ
57 GF Score
Price kr13.00
GF Value kr26.55
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Buyback Yield %?

Saniona AB LTS:0RQJ +1.72% 57 Buyback Yield % is -6.41 as of Jul. 13, 2026. GuruFocus rates LTS:0RQJ with a GF Score™ of 57/100 and a GF Value™ of kr26.55 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 742 Biotechnology companies, Saniona AB ranks better than 55.93% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Saniona AB's current buyback yield was -6.41%.


Saniona AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Saniona AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB Buyback Yield % Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 0.00 0.00 -9.50 -3.94

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -7.88 -7.13 -3.93 -5.30

LTS:0RQJ vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Saniona AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Saniona AB Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Saniona AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Saniona AB's Buyback Yield % falls into.


LTS:0RQJ
57GF Score
Saniona AB LTS:0RQJ
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Saniona AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 114.951) / 2919.3345
=-3.94%

Saniona AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 114.951) / 2142.2256
=-5.37%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -6.41 mean?
Saniona AB (LTS:0RQJ) has a Buyback Yield % of -6.41 as of Jul. 13, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Saniona AB and its competitors. According to the industry distribution chart, Saniona AB ranks #327 out of 742 companies in the Biotechnology industry, placing it in the top 44.1%.
Is Saniona AB's Buyback Yield % too high?
Saniona AB's current Buyback Yield % is -6.41. Based on the distribution chart, Saniona AB ranks #327 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Saniona AB has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Saniona AB ranks #327 out of 742 companies for Buyback Yield %. This puts Saniona AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Saniona AB and its competitors. Saniona AB's current Buyback Yield % is -6.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (LTS:0RQJ) is currently considered Significantly Undervalued. The stock's GF Value™ is kr26.55, compared to a current price of kr13.00 — trading 51% below its estimated fair value. The current Buyback Yield % is -6.41. Saniona AB's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Saniona AB (LTS:0RQJ), the current Buyback Yield % is -6.41 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saniona AB (LTS:0RQJ) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of kr13.00 is trading 51% below its estimated GF Value™ of kr26.55. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for LTS:0RQJ:

  • Buyback Yield %: -6.41
  • GF Value™: kr26.55 vs. price of kr13.00 (51% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the LTS:0RQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
57GF Score

Get the complete analysis for LTS:0RQJ

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.00
Price
kr26.55
GF Value